<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="/rss.css" type="text/css"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/"
    xmlns:cc="http://web.resource.org/cc/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:extra="http://www.w3.org/1999/xhtml"
    xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
    <channel rdf:about="http://www.epigeneticsandchromatin.com/feeds/mostaccessed/journal?quantity=&amp;format=rss&amp;version=">
        <title>Epigenetics &amp; Chromatin - Most accessed articles</title>
        <link>http://www.epigeneticsandchromatin.com</link>
        <description>The most accessed research articles published by Epigenetics &amp; Chromatin</description>
        <dc:date>2012-04-27T00:00:00Z</dc:date>
        <items>
            <rdf:Seq>
                                <rdf:li rdf:resource="http://www.epigeneticsandchromatin.com/content/5/1/5" />
                                <rdf:li rdf:resource="http://www.epigeneticsandchromatin.com/content/5/1/4" />
                                <rdf:li rdf:resource="http://www.epigeneticsandchromatin.com/content/5/1/1" />
                                <rdf:li rdf:resource="http://www.epigeneticsandchromatin.com/content/4/1/12" />
                                <rdf:li rdf:resource="http://www.epigeneticsandchromatin.com/content/4/1/9" />
                                <rdf:li rdf:resource="http://www.epigeneticsandchromatin.com/content/1/1/9" />
                                <rdf:li rdf:resource="http://www.epigeneticsandchromatin.com/content/4/1/1" />
                                <rdf:li rdf:resource="http://www.epigeneticsandchromatin.com/content/4/1/21" />
                                <rdf:li rdf:resource="http://www.epigeneticsandchromatin.com/content/2/1/10" />
                                <rdf:li rdf:resource="http://www.epigeneticsandchromatin.com/content/3/1/15" />
                            </rdf:Seq>
        </items>
                 <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </channel>
        <item rdf:about="http://www.epigeneticsandchromatin.com/content/5/1/5">
        <title>The conformational flexibility of the C-terminus of histone H4 promotes histone octamer and nucleosome stability and yeast viability</title>
        <description>Background:
The protein anti-silencing function 1 (Asf1) chaperones histones H3/H4 for assembly into nucleosomes every cell cycle as well as during DNA transcription and repair. Asf1 interacts directly with H4 through the C-terminal tail of H4, which itself interacts with the docking domain of H2A in the nucleosome. The structure of this region of the H4 C-terminus differs greatly in these two contexts.
Results:
To investigate the functional consequence of this structural change in histone H4, we restricted the available conformations of the H4 C-terminus and analyzed its effect in vitro and in vivo in S. cerevisiae.  One such mutation, H4 G94P, had modest effects on the interaction between H4 and Asf1. However, in yeast, flexibility of the C-terminal tail of H4 has essential functions that extend beyond chromatin assembly and disassembly. The H4 G94P mutation resulted in severely sick yeast although, nucleosomes still formed in vivo albeit yielding diffuse micrococcal nuclease ladders. In vitro, H4G4P had modest effects on nucleosome stability, dramatically reduced histone octamer stability, and altered nucleosome sliding ability.
Conclusions:
The functional consequences of altering the conformational flexibility in the C-terminal tail of H4 are severe.  Interestingly, despite the detrimental effects of the histone H4 G94P mutant on viability, nucleosome formation was not markedly affected in vivo.  However, histone octamer stability and nucleosome stability as well as nucleosome sliding ability were altered in vitro. These studies highlight an important role for correct interactions of the histone H4 C-terminal tail within the histone octamer and suggest that maintenance of a stable histone octamer in vivo is an essential feature of chromatin dynamics</description>
        <link>http://www.epigeneticsandchromatin.com/content/5/1/5</link>
                <dc:creator>Myrriah Chavez</dc:creator>
                <dc:creator>Jean Scorgie</dc:creator>
                <dc:creator>Briana Dennehey</dc:creator>
                <dc:creator>Seth Noone</dc:creator>
                <dc:creator>Jessica Tyler</dc:creator>
                <dc:creator>Mair Churchill</dc:creator>
                <dc:source>Epigenetics &amp; Chromatin 2012, null:5</dc:source>
        <dc:date>2012-04-27T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1756-8935-5-5</dc:identifier>
                                <prism:require>/content/figures/1756-8935-5-5-toc.gif</prism:require>
                <prism:publicationName>Epigenetics &amp; Chromatin</prism:publicationName>
        <prism:issn>1756-8935</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>5</prism:startingPage>
        <prism:publicationDate>2012-04-27T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.epigeneticsandchromatin.com/content/5/1/4">
        <title>ATP-Dependent Chromatin Remodeling in the DNA Damage Response </title>
        <description>The integrity of DNA is continuously challenged by metabolism-derived and environmental genotoxic agents that cause a variety of DNA lesions, including base alterations and breaks. DNA damage interferes with vital processes such as transcription and replication, and if not repaired properly, can ultimately lead to premature aging and cancer. Multiple DNA pathways signaling for DNA repair and DNA damage collectively safeguard the integrity of DNA. Chromatin plays a pivotal role in regulating DNA-associated processes, and is itself subject to regulation by the DNA-damage response. Chromatin influences access to DNA, and often serves as a docking or signaling site for repair and signaling proteins. Its structure can be adapted by post-translational histone modifications and nucleosome remodeling, catalyzed by the activity of ATP-dependent chromatin-remodeling complexes. In recent years, accumulating evidence has suggested that ATP-dependent chromatin-remodeling complexes play important, although poorly characterized, roles in facilitating the effectiveness of the DNA-damage response. In this review, we summarize the current knowledge on the involvement of ATP-dependent chromatin remodeling in three major DNA repair pathways: nucleotide excision repair, homologous recombination, and non-homologous end-joining. This shows that a surprisingly large number of different remodeling complexes display pleiotropic functions during different stages of the DNA-damage response. Moreover, several complexes seem to have multiple functions, and are implicated in various mechanistically distinct repair pathways.</description>
        <link>http://www.epigeneticsandchromatin.com/content/5/1/4</link>
                <dc:creator>Hannes Lans</dc:creator>
                <dc:creator>Jurgen Marteijn</dc:creator>
                <dc:creator>Wim Vermeulen</dc:creator>
                <dc:source>Epigenetics &amp; Chromatin 2012, null:4</dc:source>
        <dc:date>2012-01-30T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1756-8935-5-4</dc:identifier>
                                <prism:require>/content/figures/1756-8935-5-4-toc.gif</prism:require>
                <prism:publicationName>Epigenetics &amp; Chromatin</prism:publicationName>
        <prism:issn>1756-8935</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>4</prism:startingPage>
        <prism:publicationDate>2012-01-30T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.epigeneticsandchromatin.com/content/5/1/1">
        <title>Enhancers and silencers: an integrated and simple model for their function.</title>
        <description>Regulatory DNA elements such as enhancers, silencers and insulators are embedded in metazoan genomes, and they control gene expression during development. Although they fulfil different roles, they share specific properties. Herein we discuss some examples and a parsimonious model for their function is proposed. All are transcription units that tether their target promoters close to, or distant from, transcriptional hot spots (or &apos;factories&apos;).</description>
        <link>http://www.epigeneticsandchromatin.com/content/5/1/1</link>
                <dc:creator>Petros Kolovos</dc:creator>
                <dc:creator>Tobias Knoch</dc:creator>
                <dc:creator>Frank Grosveld</dc:creator>
                <dc:creator>Peter Cook</dc:creator>
                <dc:creator>Argyris Papantonis</dc:creator>
                <dc:source>Epigenetics &amp; Chromatin 2012, null:1</dc:source>
        <dc:date>2012-01-09T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1756-8935-5-1</dc:identifier>
                                <prism:require>/content/figures/1756-8935-5-1-toc.gif</prism:require>
                <prism:publicationName>Epigenetics &amp; Chromatin</prism:publicationName>
        <prism:issn>1756-8935</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>1</prism:startingPage>
        <prism:publicationDate>2012-01-09T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.epigeneticsandchromatin.com/content/4/1/12">
        <title>H3K9me3 binding proteins are dispensable for SETDB1/H3K9me3-dependent  retroviral silencing 
</title>
        <description>Background:
Endogenous retroviruses (ERVs) are parasitic sequences whose derepression is associated with cancer and genomic instability. Many ERV families are silenced in mouse embryonic stem cells (mESCs) via SETDB1-deposited trimethylated lysine 9 of histone 3 (H3K9me3), but the mechanism of H3K9me3-dependent repression remains unknown. Multiple proteins, including members of the heterochromatin protein 1 (HP1) family, bind H3K9me2/3 and are involved in transcriptional silencing in model organisms. In this work, we address the role of such H3K9me2/3 &quot;readers&quot; in the silencing of ERVs in mESCs.
Results:
We demonstrate that despite the reported function of HP1 proteins in H3K9me-dependent gene repression and the critical role of H3K9me3 in transcriptional silencing of class I and class II ERVs, the depletion of HP1&#945;, HP1&#946; and HP1&#947;, alone or in combination, is not sufficient for derepression of these elements in mESCs. While loss of HP1&#945; or HP1&#946; leads to modest defects in DNA methylation of ERVs or spreading of H4K20me3 into flanking genomic sequence, respectively, neither protein affects H3K9me3 or H4K20me3 in ERV bodies. Furthermore, using novel ERV reporter constructs targeted to a specific genomic site, we demonstrate that, relative to Setdb1, knockdown of the remaining known H3K9me3 readers expressed in mESCs, including Cdyl, Cdyl2, Cbx2, Cbx7, Mpp8, Uhrf1 and Jarid1a-c, leads to only modest proviral reactivation.
Conclusion:
Taken together, these results reveal that each of the known H3K9me3-binding proteins is dispensable for SETDB1-mediated ERV silencing. We speculate that H3K9me3 might maintain ERVs in a silent state in mESCs by directly inhibiting deposition of active covalent histone marks.</description>
        <link>http://www.epigeneticsandchromatin.com/content/4/1/12</link>
                <dc:creator>Irina Maksakova</dc:creator>
                <dc:creator>Preeti Goyal</dc:creator>
                <dc:creator>Jorn Bullwinkel</dc:creator>
                <dc:creator>Jeremy Brown</dc:creator>
                <dc:creator>Misha Bilenky</dc:creator>
                <dc:creator>Dixie Mager</dc:creator>
                <dc:creator>Prim Singh</dc:creator>
                <dc:creator>Matthew Lorincz</dc:creator>
                <dc:source>Epigenetics &amp; Chromatin 2011, null:12</dc:source>
        <dc:date>2011-07-20T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1756-8935-4-12</dc:identifier>
                                <prism:require>/content/figures/1756-8935-4-12-toc.gif</prism:require>
                <prism:publicationName>Epigenetics &amp; Chromatin</prism:publicationName>
        <prism:issn>1756-8935</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>12</prism:startingPage>
        <prism:publicationDate>2011-07-20T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.epigeneticsandchromatin.com/content/4/1/9">
        <title>Generation of Bivalent Chromatin Domains During Cell Fate Decisions</title>
        <description>Background:
In self-renewing, pluripotent cells, bivalent chromatin modification is thought to silence (H3K27me3) lineage control genes while &apos;poising&apos; (H3K4me3) them for subsequent activation during differentiation, implying an important role for epigenetic modification in directing cell fate decisions. However, rather than representing an equivalently balanced epigenetic mark, the patterns and levels of histone modifications at bivalent genes can vary widely and the criteria for identifying this chromatin signature are poorly defined.
Results:
Here, we initially show how chromatin status alters during lineage commitment and differentiation at a single well characterised bivalent locus. In addition we have determined how chromatin modifications at this locus change with gene expression in both ensemble and single cell analyses. We also show, on a global scale, how mRNA expression may be reflected in the ratio of H3K4me3/H3K27me3.
Conclusions:
While truly &apos;poised&apos; bivalently modified genes may exist, the original hypothesis that all bivalent genes are epigenetically premarked for subsequent expression might be oversimplistic. In fact, from the data presented in the present work, it is equally possible that many genes that appear to be bivalent in pluripotent and multipotent cells may simply be stochastically expressed at low levels in the process of multilineage priming. Although both situations could be considered to be forms of &apos;poising&apos;, the underlying mechanisms and the associated implications are clearly different.</description>
        <link>http://www.epigeneticsandchromatin.com/content/4/1/9</link>
                <dc:creator>Marco De Gobbi</dc:creator>
                <dc:creator>David Garrick</dc:creator>
                <dc:creator>Magnus Lynch</dc:creator>
                <dc:creator>Douglas Vernimmen</dc:creator>
                <dc:creator>Jim Hughes</dc:creator>
                <dc:creator>Nicolas Goardon</dc:creator>
                <dc:creator>Sidinh Luc</dc:creator>
                <dc:creator>Karen Lower</dc:creator>
                <dc:creator>Jacqueline Sloane-Stanley</dc:creator>
                <dc:creator>Cristina Pina</dc:creator>
                <dc:creator>Shamit Soneji</dc:creator>
                <dc:creator>Raffaele Renella</dc:creator>
                <dc:creator>Tariq Enver</dc:creator>
                <dc:creator>Stephen Taylor</dc:creator>
                <dc:creator>Sten Eirik Jacobsen</dc:creator>
                <dc:creator>Paresh Vyas</dc:creator>
                <dc:creator>Richard Gibbons</dc:creator>
                <dc:creator>Douglas Higgs</dc:creator>
                <dc:source>Epigenetics &amp; Chromatin 2011, null:9</dc:source>
        <dc:date>2011-06-06T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1756-8935-4-9</dc:identifier>
                            <dc:title>Are bivalently modified genes &amp;#8220;poised&amp;#8221; for expression?</dc:title>
                            <dc:description>The hypothesis that bivalently modified genes are pre-marked for subsequent activation during differentiation is questioned as being over-simplistic, as further light is shed on the generation of bivalent chromatin domains during cell fate decisions.</dc:description>
                <prism:require>/content/figures/1756-8935-4-9-toc.gif</prism:require>
                <prism:publicationName>Epigenetics &amp; Chromatin</prism:publicationName>
        <prism:issn>1756-8935</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>9</prism:startingPage>
        <prism:publicationDate>2011-06-06T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.epigeneticsandchromatin.com/content/1/1/9">
        <title>Chromatin structure and DNA damage repair</title>
        <description>The integrity of the genome is continuously challenged by both endogenous and exogenous DNA damaging agents. These damaging agents can induce a wide variety of lesions in the DNA, such as double strand breaks, single strand breaks, oxidative lesions and pyrimidine dimers. The cell has evolved intricate DNA damage response mechanisms to counteract the genotoxic effects of these lesions. The two main features of the DNA damage response mechanisms are cell-cycle checkpoint activation and, at the heart of the response, DNA repair. For both damage signalling and repair, chromatin remodelling is most likely a prerequisite. Here, we discuss current knowledge on chromatin remodelling with respect to the cellular response to DNA damage, with emphasis on the response to lesions resolved by nucleotide excision repair. We will discuss the role of histone modifications as well as their displacement or exchange in nucleotide excision repair and make a comparison with their requirement in transcription and double strand break repair.</description>
        <link>http://www.epigeneticsandchromatin.com/content/1/1/9</link>
                <dc:creator>Christoffel Dinant</dc:creator>
                <dc:creator>Adriaan Houtsmuller</dc:creator>
                <dc:creator>Wim Vermeulen</dc:creator>
                <dc:source>Epigenetics &amp; Chromatin 2008, null:9</dc:source>
        <dc:date>2008-11-12T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1756-8935-1-9</dc:identifier>
                                <prism:require>/content/figures/1756-8935-1-9-toc.gif</prism:require>
                <prism:publicationName>Epigenetics &amp; Chromatin</prism:publicationName>
        <prism:issn>1756-8935</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>9</prism:startingPage>
        <prism:publicationDate>2008-11-12T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.epigeneticsandchromatin.com/content/4/1/1">
        <title>Quantitative analysis of DNA methylation at all human imprinted regions reveals preservation of epigenetic stability in adult somatic tissue</title>
        <description>Background:
Genes subject to genomic imprinting are mono-allelically expressed in a parent-of-origin dependent manner. Each imprinted locus has at least one differentially methylated region (DMR) which has allele specific DNA methylation and contributes to imprinted gene expression. Once DMRs are established, they are potentially able to withstand normal genome reprogramming events that occur during cell differentiation and germ-line DMRs are stably maintained throughout development. These DMRs, in addition to being either maternally or paternally methylated, have differences in whether methylation was acquired in the germ-line or post fertilization and are present in a variety of genomic locations with different Cytosine-phosphate guanine (CpG) densities and CTCF binding capacities. We therefore examined the stability of maintenance of DNA methylation imprints and determined the normal baseline DNA methylation levels in several adult tissues for all imprinted genes. In order to do this, we first developed and validated 50 highly specific, quantitative DNA methylation pyrosequencing assays for the known DMRs associated with human imprinted genes.
Results:
Remarkable stability of the DNA methylation imprint was observed in all germ-line DMRs and paternally methylated somatic DMRs (which maintained average methylation levels of between 35% - 65% in all somatic tissues, independent of gene expression). Maternally methylated somatic DMRs were found to have more variation with tissue specific methylation patterns. Most DMRs, however, showed some intra-individual variability for DNA methylation levels in peripheral blood, suggesting that more than one DMR needs to be examined in order to get an overall impression of the epigenetic stability in a tissue. The plasticity of DNA methylation at imprinted genes was examined in a panel of normal and cancer cell lines. All cell lines showed changes in DNA methylation, especially at the paternal germ-line and the somatic DMRs.
Conclusions:
Our validated pyrosequencing methylation assays can be widely used as a tool to investigate DNA methylation levels of imprinted genes in clinical samples. This first comprehensive analysis of normal methylation levels in adult somatic tissues at human imprinted regions confirm that, despite intra-individual variability and tissue specific expression, imprinted genes faithfully maintain their DNA methylation in healthy adult tissue. DNA methylation levels of a selection of imprinted genes are, therefore, a valuable indicator for epigenetic stability.</description>
        <link>http://www.epigeneticsandchromatin.com/content/4/1/1</link>
                <dc:creator>Kathryn Woodfine</dc:creator>
                <dc:creator>Joanna Huddleston</dc:creator>
                <dc:creator>Adele Murrell</dc:creator>
                <dc:source>Epigenetics &amp; Chromatin 2011, null:1</dc:source>
        <dc:date>2011-01-31T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1756-8935-4-1</dc:identifier>
                                <prism:require>/content/figures/1756-8935-4-1-toc.gif</prism:require>
                <prism:publicationName>Epigenetics &amp; Chromatin</prism:publicationName>
        <prism:issn>1756-8935</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>1</prism:startingPage>
        <prism:publicationDate>2011-01-31T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.epigeneticsandchromatin.com/content/4/1/21">
        <title>Enhancer-driven chromatin interactions during development promote escape from silencing by a long non-coding RNA.</title>
        <description>Background:
Gene regulation in eukaryotes is a complex process entailing the establishment of transcriptionally silent chromatin domains interspersed with regions of active transcription. Imprinted domains consist of clusters of genes, some of which exhibit parent-of-origin dependent monoallelic expression, while others are biallelic. The Kcnq1 imprinted domain illustrates the complexities of long-range regulation that coexists with local exceptions. A paternally expressed repressive non-coding RNA, Kcnq1ot1, regulates a domain of up to 750 kb, encompassing 14 genes. We study how the Kcnq1 gene, initially silenced by Kcnq1ot1, undergoes tissue-specific escape from imprinting during development. Specifically, we uncover the role of chromosome conformation during these events.
Results:
We show that Kcnq1 transitions from monoallelic to biallelic expression during mid gestation in the developing heart. This transition is not associated with the loss of methylation on the Kcnq1 promoter. However, by exploiting chromosome conformation capture (3C) technology, we find tissue-specific and stage-specific chromatin loops between the Kcnq1 promoter and newly identified DNA regulatory elements. These regulatory elements showed in vitro activity in a luciferase assay and in vivo activity in transgenic embryos.
Conclusions:
By exploring the spatial organization of the Kcnq1 locus, our results reveal a novel mechanism by which local activation of genes can override the regional silencing effects of non-coding RNAs.</description>
        <link>http://www.epigeneticsandchromatin.com/content/4/1/21</link>
                <dc:creator>Lisa Korostowski</dc:creator>
                <dc:creator>Anjali Raval</dc:creator>
                <dc:creator>Gillian Breuer</dc:creator>
                <dc:creator>Nora Engel</dc:creator>
                <dc:source>Epigenetics &amp; Chromatin 2011, null:21</dc:source>
        <dc:date>2011-11-15T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1756-8935-4-21</dc:identifier>
                                <prism:require>/content/figures/1756-8935-4-21-toc.gif</prism:require>
                <prism:publicationName>Epigenetics &amp; Chromatin</prism:publicationName>
        <prism:issn>1756-8935</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>21</prism:startingPage>
        <prism:publicationDate>2011-11-15T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.epigeneticsandchromatin.com/content/2/1/10">
        <title>Talking to chromatin: post-translational modulation of polycomb group function</title>
        <description>Polycomb Group proteins are important epigenetic regulators of gene expression. Epigenetic control by polycomb Group proteins involves intrinsic as well as associated enzymatic activities. Polycomb target genes change with cellular context, lineage commitment and differentiation status, revealing dynamic regulation of polycomb function. It is currently unclear how this dynamic modulation is controlled and how signaling affects polycomb-mediated epigenetic processes at the molecular level. Experimental evidence on regulation of polycomb function by post-translational mechanisms is steadily emerging: Polycomb Group proteins are targeted for ubiquitylation, sumoylation and phosphorylation. In addition, specific Polycomb Group proteins modify other (chromatin) associated proteins via similar post-translational modifications. Such modifications affect protein function by affecting protein stability, protein-protein interactions and enzymatic activities. Here, we review current insights in covalent modification of Polycomb Group proteins in the context of protein function and present a tentative view of integrated signaling to chromatin in the context of phosphorylation. Clearly, the available literature reveals just the tip of the iceberg, and exact molecular mechanisms in, and the biological relevance of post-translational regulation of polycomb function await further elucidation. Our understanding of causes and consequences of post-translational modification of polycomb proteins will gain significantly from in vivo validation experiments. Impaired polycomb function has important repercussions for stem cell function, development and disease. Ultimately, increased understanding of signaling to chromatin and the mechanisms involved in epigenetic remodeling will contribute to the development of therapeutic interventions in cell fate decisions in development and disease.</description>
        <link>http://www.epigeneticsandchromatin.com/content/2/1/10</link>
                <dc:creator>Hanneke Niessen</dc:creator>
                <dc:creator>Jeroen Demmers</dc:creator>
                <dc:creator>Jan Willem Voncken</dc:creator>
                <dc:source>Epigenetics &amp; Chromatin 2009, null:10</dc:source>
        <dc:date>2009-09-01T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1756-8935-2-10</dc:identifier>
                                <prism:require>/content/figures/1756-8935-2-10-toc.gif</prism:require>
                <prism:publicationName>Epigenetics &amp; Chromatin</prism:publicationName>
        <prism:issn>1756-8935</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>10</prism:startingPage>
        <prism:publicationDate>2009-09-01T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.epigeneticsandchromatin.com/content/3/1/15">
        <title>Trans-generational epigenetic regulation of C. elegans primordial germ cells</title>
        <description>Background:
The processes through which the germline maintains its continuity across generations has long been the focus of biological research. Recent studies have suggested that germline continuity can involve epigenetic regulation, including regulation of histone modifications. However, it is not clear how histone modifications generated in one generation can influence the transcription program and development of germ cells of the next.
Results:
We show that the histone H3K36 methyltransferase maternal effect sterile (MES)-4 is an epigenetic modifier that prevents aberrant transcription activity in Caenorhabditis elegans primordial germ cells (PGCs). In mes-4 mutant PGCs, RNA Pol II activation is abnormally regulated and the PGCs degenerate. Genetic and genomewide analyses of MES-4-mediated H3K36 methylation suggest that MES-4 activity can operate independently of ongoing transcription, and may be predominantly responsible for maintenance methylation of H3K36 in germline-expressed loci.
Conclusions:
Our data suggest a model in which MES-4 helps to maintain an &apos;epigenetic memory&apos; of transcription that occurred in germ cells of previous generations, and that MES-4 and its epigenetic product are essential for normal germ cell development.</description>
        <link>http://www.epigeneticsandchromatin.com/content/3/1/15</link>
                <dc:creator>Hirofumi Furuhashi</dc:creator>
                <dc:creator>Teruaki Takasaki</dc:creator>
                <dc:creator>Andreas Rechtsteiner</dc:creator>
                <dc:creator>Tengguo Li</dc:creator>
                <dc:creator>Hiroshi Kimura</dc:creator>
                <dc:creator>Paula Checchi</dc:creator>
                <dc:creator>Susan Strome</dc:creator>
                <dc:creator>William Kelly</dc:creator>
                <dc:source>Epigenetics &amp; Chromatin 2010, null:15</dc:source>
        <dc:date>2010-08-12T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1756-8935-3-15</dc:identifier>
                                <prism:require>/content/figures/1756-8935-3-15-toc.gif</prism:require>
                <prism:publicationName>Epigenetics &amp; Chromatin</prism:publicationName>
        <prism:issn>1756-8935</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>15</prism:startingPage>
        <prism:publicationDate>2010-08-12T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
        <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks" />
    </cc:License>
</rdf:RDF>

